The Cancer Prevention and Control Program of the Mayo Clinic Cancer Center focuses on innovative approaches to improving the life of patients by preventing cancer and better managing the sometimes debilitating symptoms associated with cancer and its treatment. The Cancer Prevention and Control Program conducts research on all three Mayo Clinic campuses — Scottsdale, Ariz.; Jacksonville, Fla.; and Rochester, Minn.


Investigators in the Cancer Prevention and Control Program focus on three main areas of research:

  • Cancer prevention through tobacco control research. Tobacco use causes numerous types of cancer. Research efforts focus on preventing exposure to environmental tobacco smoke, such as community-based interventions in American Indian and Alaska Native populations. Research is also dedicated to improving the effectiveness of behavioral and pharmacological treatment for tobacco users, including use in high-need populations, such as hospitalized patients and people with alcoholism.
  • Cancer risk reduction through chemoprevention. Chemoprevention aims to inhibit or reverse the development of cancer through the use of medicines, supplements or other preparations. Research has explored the potential of chemoprevention in a wide range of target organ malignancies, including lung cancer, breast cancer, colorectal cancer, prostate cancer and others.
  • Control of cancer symptoms and side effects. This research involves a variety of investigators from many fields, including medical oncology, radiation oncology, surgical oncology, nursing oncology, gastroenterology, physical medicine, general internal medicine, complementary and alternative therapy, and psychiatry. Research has focused on such concerns as hot flashes and other menopausal symptoms associated with cancer therapy, fatigue, peripheral neuropathy caused by chemotherapy, cancer anorexia-cachexia, mucositis, and chronic pain.


The Cancer Prevention and Control Program has two co-leaders: